Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Dec 19, 2023 1:03pm
52 Views
Post# 35792031

RE:RE:Gilles destroyer of shareholders

RE:RE:Gilles destroyer of shareholdersDoes anyone believe AEZS could issue more shares to raise funds for their pipeline given their track record?

More recently, shares were issued in Feb. 19, 2021 at $1.45. Shares were trading for $37 USD taking into acount the 1 for 25 share rollback. On July 22, 2022 they went for the share consolidation and shares were $4.83. That's a 94% shrinkage in the share price. Since that consolidation, today they are trading for just over $2, a futher decline of about 60% in a year and a half. Keep in mind that post merger, they plan to consolidate shares on a 1 to 3 or 1 to 4 basis.

The new AEZS will tout the potential of PGX to allow them to issue more paper, else they can't lure new investors on the old and tired story of Macimorelin. Management's current low or zero share ownership shows they are very unlikely to participate in any share offering.

This merger is BS, and appropriately, from SmallCaps Discoveries, "In the end, you are looking for a management team that treats all resources, especially its shares, like gold, not toilet paper."
<< Previous
Bullboard Posts
Next >>